Business Standard

Friday, December 27, 2024 | 03:58 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

GSK Pharma to pare brands to 20 in India, bring new products into country

The company will launch brand extensions whenever needed and focus on bringing in patented product

The revenue from operations declined to ~69.7 bn for the fourth quarter against ~71.3 bn during the same period last year
Premium

The revenue from operations declined to ~69.7 bn for the fourth quarter against ~71.3 bn during the same period last year

Sohini Das Mumbai
British drugmaker GlaxoSmithKline Pharmaceuticals is working on a strategy to reduce the number of brands in India to around 20 from 130, and bring in more patented products from the parent to the country.

This would not only enable the company to simplify its operations, analysts say this is a strategic move by the drugmaker to focus on high-price and high-margin products.

Talking to Business Standard, Annaswamy Vaidheesh, vice-president, South Asia, and managing director for India, GSK Pharma, said: “We have decided to have fewer brands. This not only simplifies our operations but also enables us to put our energy

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in